Biotech Direct
@biotechdirect.bsky.social
At the intersection of innovation and opportunity, we focus on dynamic public markets within the biotech and life sciences sectors, where cutting-edge advancements meet the potential for substantial growth.
Substack: https://biotechdirect.substack.com
Substack: https://biotechdirect.substack.com
Analyst rating update $INCY
Buy: 7(-2), Outperform: 3(-1), Hold: 16(+2), Underperform: 1(0), Sell: 0(0).
Buy: 7(-2), Outperform: 3(-1), Hold: 16(+2), Underperform: 1(0), Sell: 0(0).
March 19, 2025 at 11:18 PM
Analyst rating update $INCY
Buy: 7(-2), Outperform: 3(-1), Hold: 16(+2), Underperform: 1(0), Sell: 0(0).
Buy: 7(-2), Outperform: 3(-1), Hold: 16(+2), Underperform: 1(0), Sell: 0(0).
Portfolio Update #1 - Portfolio as at 19 March 2025
Link in comments below 👇
Link in comments below 👇
March 19, 2025 at 10:25 PM
Portfolio Update #1 - Portfolio as at 19 March 2025
Link in comments below 👇
Link in comments below 👇
Welcome to Biotech Direct. Check out the purpose of the site and what I hope you will get out of it.
biotechdirect.substack.com/p/welcome-to...
biotechdirect.substack.com/p/welcome-to...
Welcome to Biotech Direct
Overview of the site, the content and my reasons for this project.
biotechdirect.substack.com
March 19, 2025 at 11:48 AM
Welcome to Biotech Direct. Check out the purpose of the site and what I hope you will get out of it.
biotechdirect.substack.com/p/welcome-to...
biotechdirect.substack.com/p/welcome-to...
Edgewise Therapeutics - $EWTX (Nasdaq)
Link in comment below👇
Link in comment below👇
March 19, 2025 at 10:35 AM
Edgewise Therapeutics - $EWTX (Nasdaq)
Link in comment below👇
Link in comment below👇
Looking to connect with anyone in the biotech, life sciences and healthcare sectors. I focus on investment ideas in US public companies in the above sectors with MC below $15b. Reach out and say hi. 👋
March 18, 2025 at 10:59 PM
Looking to connect with anyone in the biotech, life sciences and healthcare sectors. I focus on investment ideas in US public companies in the above sectors with MC below $15b. Reach out and say hi. 👋
Reposted by Biotech Direct
Ascendis Pharma A/S - $ASND (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Ascendis Pharma A/S - $ASND (Nasdaq)
Applying our innovative technology platform to build a leading, fully integrated global biopharmaceutical company
open.substack.com
March 18, 2025 at 2:13 AM
Ascendis Pharma A/S - $ASND (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Reposted by Biotech Direct
Reposted by Biotech Direct
BofA fund manager survey: biggest drop in US equity allocation on record
March 18, 2025 at 9:15 AM
BofA fund manager survey: biggest drop in US equity allocation on record
Ascendis Pharma A/S - $ASND (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Ascendis Pharma A/S - $ASND (Nasdaq)
Applying our innovative technology platform to build a leading, fully integrated global biopharmaceutical company
open.substack.com
March 18, 2025 at 2:13 AM
Ascendis Pharma A/S - $ASND (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
At the intersection of innovation and opportunity, we focus on the dynamic public market within the biotech and life sciences sectors, where cutting-edge advancements meet the potential for substantial growth.
Substack: biotechdirect.substack.com
Substack: biotechdirect.substack.com
Biotech Direct | Substack
At the intersection of innovation and opportunity, we focus on the dynamic public market within the biotech and life sciences sectors, where cutting-edge advancements meet the potential for substantia...
biotechdirect.substack.com
March 17, 2025 at 9:10 AM
At the intersection of innovation and opportunity, we focus on the dynamic public market within the biotech and life sciences sectors, where cutting-edge advancements meet the potential for substantial growth.
Substack: biotechdirect.substack.com
Substack: biotechdirect.substack.com
Summit Therapeutics - $SMMT (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Summit Therapeutics - $SMMT (Nasdaq)
Biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal therapyies.
open.substack.com
March 17, 2025 at 9:08 AM
Summit Therapeutics - $SMMT (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Candel Therapeutics - $CADL (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Candel Therapeutics - $CADL (Nasdaq)
The cancer treatment paradigm has shifted dramatically, providing evidence that the immune system can be educated to recognize and eliminate the patient’s tumor cells.
open.substack.com
March 17, 2025 at 9:08 AM
Candel Therapeutics - $CADL (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Grail - $GRL (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Grail - $GRL (Nasdaq)
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative and effective technology.
open.substack.com
March 17, 2025 at 9:08 AM
Grail - $GRL (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Ionis Pharmaceuticals - $IONS (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...
Ionis Pharmaceuticals - $IONS (Nasdaq)
Building on a rich history in pioneering RNA-targeted medicines to continue transforming outcomes for patients in our focus areas of neurology, cardiology and select areas of high patient needs.
open.substack.com
March 17, 2025 at 9:07 AM
Ionis Pharmaceuticals - $IONS (Nasdaq)
open.substack.com/pub/biotechd...
open.substack.com/pub/biotechd...